NEWMarkets

ADC Therapeutics SA (ADCT) Files Form 13G on April 24

Published on 4/25/2026

#ADCT#Form13G#ownership#filing
ADC Therapeutics SA (ADCT) Files Form 13G on April 24

AI Summary

ADC Therapeutics SA (ADCT) filed Form 13G on April 24. This document is typically filed by investors owning more than 5% of a company’s securities, indicating a significant stake. The filing reflects changes in beneficial ownership and is critical for transparency in market transactions. Monitoring such filings helps investors understand the shareholder dynamics that can influence stock performance.

Source: Read original article (opens in new tab)

Related News

Terawulf (WULF) CTO Khan Sells 452,152 Shares Impacting Stock
Markets

Terawulf (WULF) CTO Khan Sells 452,152 Shares Impacting Stock

Apr 25

Kinetik Holdings (KNTK) Stock Sale Reaches $7.7 Million
Markets

Kinetik Holdings (KNTK) Stock Sale Reaches $7.7 Million

Apr 24

Onconetix (ONTX) Announces Board Changes and New Appointments
Markets

Onconetix (ONTX) Announces Board Changes and New Appointments

Apr 24

Nuvve (NVVE) faces potential Nasdaq delisting due to price rule
Markets

Nuvve (NVVE) faces potential Nasdaq delisting due to price rule

Apr 24